A Multivalent Mannheimia-Bibersteinia Vaccine Protects Bighorn Sheep against Mannheimia haemolytica Challenge
ABSTRACTBighorn sheep (BHS) are more susceptible than domestic sheep (DS) toMannheimia haemolyticapneumonia. Although both species carryM. haemolyticaas a commensal bacterium in the nasopharynx, DS carry mostly leukotoxin (Lkt)-positive strains while BHS carry Lkt-negative strains. Consequently, antibodies to surface antigens and Lkt are present at much higher titers in DS than in BHS. The objective of this study was to determine whether repeated immunization of BHS with multivalentMannheimia-Bibersteiniavaccine will protect them uponM. haemolyticachallenge. Four BHS were vaccinated with a culture supernatant vaccine prepared fromM. haemolyticaserotypes A1 and A2 andBibersteinia trehalosiserotype T10 on days 0, 21, 35, 49, and 77. Four other BHS were used as nonvaccinated controls. On the day of challenge, 12 days after the last immunization, the mean serum titers of Lkt-neutralizing antibodies and antibodies to surface antigens againstM. haemolyticawere 1:160 and 1:4,000, respectively. Following intranasal challenge withM. haemolyticaA2 (1 × 105CFU), all four control BHS died within 48 h. Necropsy revealed acute fibrinonecrotic pneumonia characteristic ofM. haemolyticainfection. None of the vaccinated BHS died during the 8 weeks postchallenge observation period. Radiography at 3 weeks postchallenge revealed no lung lesions in two vaccinated BHS and mild lesions in the other two, which resolved by 8 weeks postchallenge. These results indicate that if BHS can be induced to develop high titers of Lkt-neutralizing antibodies and antibodies to surface antigens, they are likely to surviveM. haemolyticachallenge which is likely to reduce the BHS population decline due to pneumonia.